By Matthew J. Ben, MD
Albany Gastroenterology Consultants
St. Peter’s Hospital
Maintaining healthy behaviors as we move into autumn can be a challenge. The weather is getting cooler, the days are getting shorter, and the urge to take up residence on the couch is getting stronger. But, that slower pace can be a good time to take stock of your personal health, especially if you have a serious or chronic medical condition.
A hidden epidemic is surging in the United States. Infectious disease experts estimate there could be as many as 4.7 million Americans living with hepatitis C – a potentially fatal, blood-borne virus which affects the liver.
Fueling the epidemic, half of those infected are unaware they even have the virus. And of those, less than 9 percent have received treatment.
While anyone can get hepatitis C, more than 75 percent of adults infected are baby boomers. For that reason, New York state requires health-care providers to offer testing to any person born between 1945 and 1965. The CDC recommends any person with an increased risk get tested.
You may be at an increased risk for hepatitis C if you:
• were born between 1945 and 1965
• have injected illegal drugs (even if it was only once, many years ago)
• received clotting factor concentrates made before 1987
• received blood transfusions or solid organ transplants before July 1992, or from a donor who later tested positive
• received long-term hemodialysis treatment
• have HIV infection
• have signs or symptoms of liver disease (e.g., abnormal liver enzyme tests)
• are a health-care worker who experienced a needle stick involving HCV-positive blood.
Additionally, the CDC recommends children born to a mother with hepatitis C be tested after 18 months of age.
A simple blood test is used determine if a person has the virus. A primary care provider, gastroenterologist or liver specialist, such as a hepatologist, can order this test for you.
Treatments for hepatitis C, and its six genotypes, continue to develop at a rapid pace. Where specific drugs were once used to treat different genotypes of the virus, today all genotypes can be successfully treated with one pan-genotypic drug – a drug which treats numerous genotypes. Talk with your doctor and check with your insurance provider to see what they cover, before deciding on a course of treatment.
For more information on hepatitis C testing and treatment options available, visit www.sphp.com or contact St. Peter’s Health Partners at 877-525-2227.
LiveSmart supports the Classroom Enrichment Fund at the Community Foundation for the Greater Capital Region and is made possible by donations from St. Peter’s Health Partners and Price Chopper, with promotional services provided by the Times Union and WNYT/NewsChannel 13. LiveSmart is compiled by Helen Susan Edelman, Project Director. This project ensures 70,000 students and teachers in the Capital Region have equal access to news content during the school year.